|
1.
|
Thun MJ, Namboodiri MM and Heath CW Jr:
Aspirin use and reduced risk of fatal colon cancer. N Engl J Med.
325:1593–1596. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Kawamori T, Rao CV, Seibert K and Reddy
BS: Chemopreventive activity of celecoxib, a specific
cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer
Res. 58:409–412. 1998.PubMed/NCBI
|
|
3.
|
Harris RE, Alshafie GA, Abou-Issa H and
Seibert K: Chemoprevention of breast cancer in rats by celecoxib, a
cyclooxygenase 2 inhibitor. Cancer Res. 60:2101–2103.
2000.PubMed/NCBI
|
|
4.
|
Half E, Tang XM, Gwyn K, Sahin A, Wathen K
and Sinicrope FA: Cyclooxygenase-2 expression in human breast
cancers and adjacent ductal carcinoma in situ. Cancer Res.
62:1676–1681. 2002.PubMed/NCBI
|
|
5.
|
Hida T, Yatabe Y, Achiwa H, Muramatsu H,
Kozaki K, Nakamura S, Ogawa M, Mitsudomi T, Sugiura T and Takahashi
T: Increased expression of cyclooxygenase 2 occurs frequently in
human lung cancers, specifically in adenocarcinomas. Cancer Res.
58:3761–3764. 1998.PubMed/NCBI
|
|
6.
|
Okami J, Yamamoto H, Fujiwara Y, Tsujie M,
Kondo M, Noura S, Oshima S, Nagano H, Dono K, Umeshita K, Ishikawa
O, et al: Overexpression of cyclooxygenase-2 in carcinoma of the
pancreas. Clin Cancer Res. 5:2018–2024. 1999.PubMed/NCBI
|
|
7.
|
Oshima H, Oshima M, Inaba K and Taketo MM:
Hyperplastic gastric tumors induced by activated macrophages in
COX-2/mPGES-1 transgenic mice. EMBO J. 23:1669–1678. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Krysan K, Reckamp KL, Dalwadi H, Sharma S,
Rozengurt E, Dohadwala M and Dubinett SM: Prostaglandin
E2 activates mitogen-activated protein kinase/Erk
pathway signaling and cell proliferation in non-small cell lung
cancer cells in an epidermal growth factor receptor-independent
manner. Cancer Res. 65:6275–6281. 2005.
|
|
9.
|
Han C and Wu T: Cyclooxygenase-2-derived
prostaglandin E2 promotes human cholangiocarcinoma cell
growth and invasion through EP1 receptor-mediated activation of the
epidermal growth factor receptor and Akt. J Biol Chem.
280:24053–24063. 2005.PubMed/NCBI
|
|
10.
|
Buchanan FG, Wang D, Bargiacchi F and
DuBois RN: Prostaglandin E2 regulates cell migration via
the intracellular activation of the epidermal growth factor
receptor. J Biol Chem. 278:35451–35457. 2003.PubMed/NCBI
|
|
11.
|
Chang SH, Liu CH, Conway R, Han DK,
Nithipatikom K, Trifan OC, Lane TF and Hla T: Role of prostaglandin
E2-dependent angiogenic switch in cyclooxygenase
2-induced breast cancer progression. Proc Natl Acad Sci USA.
101:591–596. 2004.
|
|
12.
|
Denkert C, Köbel M, Berger S, Siegert A,
Leclere A, Trefzer U and Hauptmann S: Expression of cyclooxygenase
2 in human malignant melanoma. Cancer Res. 61:303–308.
2001.PubMed/NCBI
|
|
13.
|
Singh T and Katiyar SK: Green tea
catechins reduce invasive potential of human melanoma cells by
targeting COX-2, PGE2 receptors and
epithelial-to-mesenchymal transition. PLoS One. 6:e252242011.
View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Vaid M, Singh T and Katiyar SK: Grape seed
proanthocyanidins inhibit melanoma cell invasiveness by reduction
of PGE2 synthesis and reversal of
epithelial-to-mesenchymal transition. PLoS One. 6:e215392011.
View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Singh T, Vaid M, Katiyar N, Sharma S and
Katiyar SK: Berberine, an isoquinoline alkaloid, inhibits melanoma
cancer cell migration by reducing the expressions of
cyclooxygenase-2, prostaglandin E2 and prostaglandin
E2 receptors. Carcinogenesis. 32:86–92. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Torisu H, Ono M, Kiryu H, Furue M, Ohmoto
Y, Nakayama J, Nishioka Y, Sone S and Kuwano M: Macrophage
infiltration correlates with tumor stage and angiogenesis in human
malignant melanoma: possible involvement of TNFalpha and IL-1alpha.
Int J Cancer. 85:182–188. 2000. View Article : Google Scholar
|
|
17.
|
Varney ML, Johansson SL and Singh RK:
Tumour-associated macrophage infiltration, neovascularization and
aggressiveness in malignantmelanoma: role of monocyte chemotactic
protein-1 and vascular endothelial growth factor-A. Melanoma Res.
15:417–425. 2005. View Article : Google Scholar
|
|
18.
|
Nakasone Y, Fujimoto M, Matsushita T,
Hamaguchi Y, Huu DL, Yanaba M, Sato S, Takehara K and Hasegawa M:
Host-derived MCP-1 and MIP-1α regulate protective anti-tumor
immunity to localized and metastatic B16 melanoma. Am J Pathol.
180:365–374. 2012.
|
|
19.
|
Oshima H, Hioki K, Popivanova BK, Oguma K,
Van Rooijen N, Ishikawa TO and Oshima M: Prostaglandin
E2 signaling and bacterial infection recruit
tumor-promoting macrophages to mouse gastric tumors.
Gastroenterology. 140:596–607.e7. 2011.
|
|
20.
|
Siegle I, Klein T, Backman JT, Saal JG,
Nüsing RM and Fritz P: Expression of cyclooxygenase 1 and
cyclooxygenase 2 in human synovial tissue: differential elevation
of cyclooxygenase 2 in inflammatory joint diseases. Arthritis
Rheum. 41:122–129. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Ratcliffe MJ, Walding A, Shelton PA,
Flaherty A and Dougall IG: Activation of E-prostanoid4 and
E-prostanoid2 receptors inhibits TNF-alpha release from human
alveolar macrophages. Eur Respir J. 29:986–994. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Fennekohl A, Sugimoto Y, Segi E, Maruyama
T, Ichikawa A and Püschel GP: Contribution of the two Gs-coupled
PGE2-receptors EP2-receptor and EP4-receptor to the
inhibition by PGE2 of the LPS-induced TNFalpha-formation
in Kupffer cells from EP2-or EP4-receptor-deficient mice. Pivotal
role for the EP4-receptor in wild type Kupffer cells. J Hepatol.
36:328–334. 2002.PubMed/NCBI
|
|
23.
|
Wang MT, Honn KV and Nie D:
Cyclooxygenases, prostanoids, and tumor progression. Cancer
Metastasis Rev. 26:525–534. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Fujita M, Kohanbash G, Fellows-Mayle W,
Hamilton RL, Komohara Y, Decker SA, Ohlfest JR and Okada H: COX-2
blockade suppresses gliomagenesis by inhibiting myeloid-derived
suppressor cells. Cancer Res. 71:2664–2674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Chell SD, Witherden IR, Dobson RR,
Moorghen M, Herman AA, Qualtrough D, Williams AC and Paraskeva C:
Increased EP4 receptor expression in colorectal cancer progression
promotes cell growth and anchorage independence. Cancer Res.
66:3106–3113. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Zhang Y and Daaka Y: PGE2
promotes angiogenesis through EP4 and PKA Cγ pathway. Blood.
118:5355–5364. 2011.
|
|
27.
|
Timoshenko AV, Xu G, Chakrabarti S, Lala
PK and Chakraborty C: Role of prostaglandin E2 receptors
in migration of murine and human breast cancer cells. Exp Cell Res.
289:265–274. 2003.PubMed/NCBI
|
|
28.
|
Sheng H, Shao J, Washington MK and DuBois
RN: Prostaglandin E2 increases growth and motility of
colorectal carcinoma cells. J Biol Chem. 276:18075–18081.
2001.PubMed/NCBI
|
|
29.
|
Pozzi A, Yan X, Macias-Perez I, Wei S,
Hata AN, Breyer RM, Morrow JD and Capdevila JH: Colon carcinoma
cell growth is associated with prostaglandin E2/EP4
receptor-evoked ERK activation. J Biol Chem. 279:29797–29804. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Conti I and Rollins BJ: CCL2 (monocyte
chemoattractant protein-1) and cancer. Semin Cancer Biol.
14:149–154. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Harlin H, Meng Y, Peterson AC, Zha Y,
Tretiakova M, Slingluff C, McKee M and Gajewski TF: Chemokine
expression in melanoma metastases associated with CD8+
T-cell recruitment. Cancer Res. 69:3077–3085. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Zhang T, Somasundaram R, Berencsi K,
Caputo L, Gimotty P, Rani P, Guerry D, Swoboda R and Herlyn D:
Migration of cytotoxic T lymphocytes toward melanoma cells in
three-dimensional organotypic culture is dependent on CCL2 and
CCR4. Eur J Immunol. 36:457–467. 2006. View Article : Google Scholar : PubMed/NCBI
|
